Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis

BACKGROUND: Renal anemia is a severe complication of chronic kidney disease (CKD) and may worsen its prognosis. Roxadustat is the only oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that has been proved effective to treat renal anemia. However, effects of roxadustat on non-dial...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Transl Med
Main Authors: Jia, Linpei, Dong, Xingtong, Yang, Jingyan, Jia, Rufu, Zhang, Hongliang
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989965/
https://ncbi.nlm.nih.gov/pubmed/32042736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.12.18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki